Trial Profile
Randomized Phase II Trial of Aspirin and Difluoromethylornithine (DFMO) in Patients at High Risk of Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Eflornithine (Primary)
- Indications Adenoma; Colon cancer; Colorectal cancer
- Focus Therapeutic Use
- 23 Aug 2019 Status changed from active, no longer recruiting to completed.
- 23 Aug 2019 Status changed from active, no longer recruiting to completed.
- 09 Oct 2015 Planned primary completion date changed from 1 Feb 2016 to 1 Oct 2016 as reported by ClinicalTrials.gov record.